Ilaria Franceschini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ilaria Franceschini has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Francesco Cilurzo
Department of Pharmaceutical Science, University of Milan, Via G. Colombo, 71, Milan 20133, Italy
3 shared publications - Paola Minghetti
University of Milan
3 shared publications - Francesca Selmin
Department of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy
2 shared publications - Antonella Casiraghi
University of Milano, Department of Pharmaceutical Sciences, Via Giuseppe Colombo 71 - 20133 Milano, Italy
1 shared publication - Chiara Sinico
Dipartimento di Scienze della Vita e dell’Ambiente, Sezione di Scienze del Farmaco, CNBS, Università degli Studi di Cagliari, 09124 Cagliari, Italy
1 shared publication - Elena Pini
Department of Pharmaceutical Sciences, University of Milan, via L. Mangiagalli 25, 20133 Milano, Italy
1 shared publication
Latest Publications
- 1 January 2016
- Published by Elsevier in Carbohydrate Polymers
- Vol. 136, 676-681
Nanofiller for the mechanical reinforcement of maltodextrins orodispersible films
- 1 January 2016
- Published by Elsevier in Carbohydrate Polymers
- Vol. 136, 676-681
Nanofiller for the mechanical reinforcement of maltodextrins orodispersible films
- 1 May 2015
- Published by Elsevier in Carbohydrate Polymers
- Vol. 121, 217-223
Maltodextrin fast dissolving films for quercetin nanocrystal delivery. A feasibility study
- 1 May 2015
- Published by Elsevier in Carbohydrate Polymers
- Vol. 121, 217-223
Maltodextrin fast dissolving films for quercetin nanocrystal delivery. A feasibility study
- 1 January 2015
- Published by Elsevier in Carbohydrate Polymers
- Vol. 115, 613-616
Aminoacids as non-traditional plasticizers of maltodextrins fast-dissolving films
- 1 January 2015
- Published by Elsevier in Carbohydrate Polymers
- Vol. 115, 613-616
Aminoacids as non-traditional plasticizers of maltodextrins fast-dissolving films
- 1 October 2014
- Vol. 66 (5) , 355-62
Is propranolol compounding from tablet safe for pediatric use? Results from an experimental test.
Although propranolol is widely used in the treatment of infantile hemangiomas, the standard 40 mg tablet needs to be fractioned to obtain 10 mg parts, with even lower doses (i.e., 2-3 mg/kg/day divided into 2-3 daily doses) required in infants. This study evaluated the weight and dose uniformity in split quarters of propranolol tablets. Twenty pharmacy students split 70 propranolol tablets by using a kitchen knife in order to obtain 200 quarters, which were considered integral and adequate for administration. Intact tablets and quarters were weighed. The content of propranolol in tablet quarters was determined on 200 quarters by using high performance liquid chromatography. Overall, 265 parts (94.6%) were integral and 213 (76.1%) were considered as adequate for administration. The mean (± standard deviation) weight of quarters judged as suitable and non-suitable for administration was 49.56 ± 5.27 mg and 46.24 ± 7.53 mg, respectively. Splitting caused a mean weight loss in each tablet of 2.97 ± 2.91 mg (median 2.06 mg). The percentage of quarters with weight lower than theoretical was 55.88%, and the remaining weighted more than expected. The mean propranolol content in quarters was 9.52 ± 0.96 mg (median 9.42 mg, range 7.36-12.23 mg) and 42% of quarters were out of the ± 10% acceptance range. The manual splitting of propranolol 40 mg tablets produced a significant proportion of quarters not suitable for administration in children or with a weight and/or an active concentration outside of the required range. The availability of a pediatric oral solution of propranolol will reduce the risk of incorrect dosing.
- 1 October 2014
- Vol. 66 (5) , 355-62
Is propranolol compounding from tablet safe for pediatric use? Results from an experimental test.
Although propranolol is widely used in the treatment of infantile hemangiomas, the standard 40 mg tablet needs to be fractioned to obtain 10 mg parts, with even lower doses (i.e., 2-3 mg/kg/day divided into 2-3 daily doses) required in infants. This study evaluated the weight and dose uniformity in split quarters of propranolol tablets. Twenty pharmacy students split 70 propranolol tablets by using a kitchen knife in order to obtain 200 quarters, which were considered integral and adequate for administration. Intact tablets and quarters were weighed. The content of propranolol in tablet quarters was determined on 200 quarters by using high performance liquid chromatography. Overall, 265 parts (94.6%) were integral and 213 (76.1%) were considered as adequate for administration. The mean (± standard deviation) weight of quarters judged as suitable and non-suitable for administration was 49.56 ± 5.27 mg and 46.24 ± 7.53 mg, respectively. Splitting caused a mean weight loss in each tablet of 2.97 ± 2.91 mg (median 2.06 mg). The percentage of quarters with weight lower than theoretical was 55.88%, and the remaining weighted more than expected. The mean propranolol content in quarters was 9.52 ± 0.96 mg (median 9.42 mg, range 7.36-12.23 mg) and 42% of quarters were out of the ± 10% acceptance range. The manual splitting of propranolol 40 mg tablets produced a significant proportion of quarters not suitable for administration in children or with a weight and/or an active concentration outside of the required range. The availability of a pediatric oral solution of propranolol will reduce the risk of incorrect dosing.